AA

Abdul Ahad Desai

Active Director Director DIN 10740355
DIN 10740355 First appointment Aug 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Abdul Ahad Desai

Data last updated:

Abdul Ahad Desai is a Director at Junsha Pharmaceuticals Private Limited (since 2024). The company operates in Paper. Junsha Pharmaceuticals Private Limited reported revenue of ₹82,000 (FY 2025).

DIN 10740355
Primary Designation Director
Industry Paper
First Appointment 12 Aug 2024
Oldest Company Age 2 yrs
Largest company Junsha Pharmaceuticals Private Limited · ₹82,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Aug 20242024₹82,000 (FY 2025)Active

Board colleagues of Abdul Ahad Desai

Directorship timeline

Open interactive timeline →
Junsha Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abdul Ahad Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Ahad Desai

Abdul Ahad Desai currently holds 1 directorship: Junsha Pharmaceuticals Private Limited (Director, since 12 Aug 2024, revenue ₹82,000 (FY 2025)).

Abdul Ahad Desai was first appointed on 12 Aug 2024 as Director at Junsha Pharmaceuticals Private Limited.

The current boards of Abdul Ahad Desai's companies include Firinbanu Abdulsattar Mansuri (Junsha Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available